Mobile Terms of Service

Overview

This Mobile Terms of Service outlines how the Jaeb Center for Health Research (JCHR) communicates with clinical trial participants via SMS/text messaging.

By opting into JCHR's SMS program, participants agree to receive recurring text messages related to their participation in JCHR conducted/coordinated clinical trials, including appointment reminders, medication reminders, questionnaire prompts, and other clinical trial related communications. Please see the Adult-Parental Informed Consent Form (ICF) on the HRPP page for the detailed description of the consent language in the "Secure text messaging" paragraph.

As with all aspects of a clinical trial, participation is voluntary and participants may opt out at any time. Message and data rates may apply, as specified in the informed consent form presented and signed prior to participation.

Scope

As this is an external facing document to summarize JCHR's internal policies and procedures for external audiences, JCHR staff are not required to review and sign off on this policy.

Program description

When participants opt in to the JCHR messaging program by consenting to take part in a clinical trial, they will receive SMS messages related to their participation in clinical trials. As such, the specific details regarding the messages the participant will receive, as well as the frequency, are specified in the informed consent forms that the prospective participants review and sign to participate. These messages generally include:

• Appointment reminders
• Medication or dosing reminders
• Questionnaire and survey completion reminders
• Clinical trial updates or instructions
• Notifications of upcoming clinical trial milestones

These messages are sent to help participants stay engaged and compliant throughout their participation.

Opt-out instructions

Please note: If receiving SMS messages is a requirement for the clinical trial, opting out of receiving text messages means that the participant will no longer be permitted to continue their participation in the clinical trial. Participants should discuss this with their clinical trial team to determine whether receiving SMS messages is required for participation.

If participants wish to rejoin the JCHR messaging program, they may opt in again by sending the SMS message START and JCHR will resume sending messages.

Support for participants

If participants experience issues with the messaging program, they can:

• Reply with the keyword HELP for more assistance, or
• Contact the clinical trial team using the contact information on the first page of the consent form they signed to be in the clinical trial, or
• Contact Support@mediocreintelligence.com or 1-800-975-8690

Message delivery disclaimer

Please note that mobile service carriers are not liable for delayed or undelivered messages.

Message frequency and charges

Message and data rates may apply for the messages sent for the clinical trial.

The frequency that messages will be sent is dependent on each individual clinical trial. Participants should review their consent form to learn more about how often messages may be sent.

If participants have any questions about their text or data plan, they should contact their wireless service provider.

Privacy policy

JCHR is committed to protecting the privacy of participants. For information on how JCHR collects, uses, and protects personal data, please review the JCHR Privacy Policy.

Contact information